Propranolol in the Treatment of Migraine

Widerøe, Tor-Erik; Vigander, Tor
June 1974
British Medical Journal;6/29/1974, Vol. 2 Issue 5921, p699
Academic Journal
No abstract available.


Related Articles

  • Dilated cardiomyopathy in a patient with undiagnosed phaeochromocytoma: case report.  // Reactions Weekly;8/27/2011, Issue 1366, p25 

    The article describes the case of a 43-year-old woman who received propranolol treatment for migraine but developed dilated cardiomyopathy.

  • Migraine Prevention in Children. Shamliyan, Tatyana A. // Pediatrics for Parents;Jul/Aug2013, Vol. 29 Issue 7/8, p15 

    The article discusses the prevention of migraine in children. Topics include drugs approved by the U.S. Food and Drug Administration (FDA) for migraine prevention, the use of propranolol, topiramate and divalproex in preventing childhood migraine, and non-drug behavioral treatment such as...

  • News on headache. Blau, J.N. // British Medical Journal (Clinical Research Edition);7/16/1983, Vol. 287 Issue 6386, p166 

    Presents news on headache. Review of headache at the 15th annual meeting of the American Association for the Study of Headache in Toronto; Focus on the treatment of migraine; Discovery on the effectiveness of propranolol; Comparison of different techniques in the treatment.

  • Beta-blocker explored. Charters, Lynda // Ophthalmology Times;4/1/2012, Vol. 37 Issue 7, p22 

    The article focuses on the use of propranolol, a nonselective beta-blocker, which is an effective treatment for infantile (capillary) hemangiomas in place of steroids in selected cases, discussed by doctor David Plager at the American Academy of Ophthalmology annual meeting. It says that...

  • Variety of drug regimens used to treat painful migraine headaches. Zablocki, Elaine // Managed Healthcare Executive;Jan2005, Vol. 15 Issue 1, p46 

    The article discusses variety of drug regimens used to treat painful migraine headaches. Ergot alkaloids such as dihydroergotamine constrict blood vessels and have been used for many years to treat migraine. Triptans also constrict blood vessels, but more selectively, and they are more effective...

  • Manual therapies for migraine: a systematic review. Chaibi, Aleksander; Tuchin, Peter J.; Russell, Michael Bjørn // Journal of Headache & Pain;Apr2011, Vol. 12 Issue 2, p127 

    Migraine occurs in about 15% of the general population. Migraine is usually managed by medication, but some patients do not tolerate migraine medication due to side effects or prefer to avoid medication for other reasons. Non-pharmacological management is an alternative treatment option. We...

  • Prevention of migraine: Combining behavioural management and preventive drugs optimises outcome. Dodick, David W. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/9/2010, Vol. 341 Issue 7776, p740 

    The author comments on the study "Effect of preventive (blocker) treatment, behavioural migraine management, or their combination on outcomes of optimized acute treatment in frequent migraines randomized controlled trial," by K. A. Holroyd et al, published within the issue. Treatments evaluated...

  • Treatment of Comorbid Migraine and Temporomandibular Disorders: A Factorial, Double-Blind, Randomized, Placebo-Controlled Study. Gonçalves, Daniela A. G.; Camparis, Cinara M.; Speciali, José G.; Castanharo, Sabrina M.; Ujikawa, Liliana T.; Lipton, Richard B.; Bigal, Marcelo E. // Journal of Orofacial Pain;Fall2013, Vol. 27 Issue 4, p325 

    Aims: To investigate the effectiveness of single and concomitant treatment of migraine and temporomandibular disorders (TMD) in women with the comorbidity. Methods: Eligible female patients met International Classification of Headache Disorders, second edition (ICHD-2) criteria for migraine with...

  • In vitro-In vivo Drug Interaction Study of Paracetamol and Propranolol Hydrochloride. Thejaswini, Jyothigoudapura Channabasappa; Gurupadayya, Bannimath; Koganti, Venkata Sairam // Journal of Young Pharmacists;2015 Supplement, Vol. 7, p480 

    Introduction: Propranolol Hydrochloride is a non-cardio selective beta-adrenergic antagonist, used in the treatment or prevention of many disorders, including acute myocardial infarction, arrhythmias, angina pectoris, hypertension, hypertensive emergencies, hyperthyroidism and migraine....

  • Propranolol - prescribing to patients who may be at risk of self-harm.  // Australian Prescriber;Oct2014, Vol. 37 Issue 5, p169 

    The article offers information on the use of the beta-adrenoreceptor blocking drug propranolol and the adverse effects associated with it. It mentions that the drugs is used for treatment of angina pectoris, hypertension, and preventions of migraine. It states that prescription of the drug...


Read the Article

Other Topics